NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/08/2023
Back to search
Official data from USPTO
ANAGENEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
14
Latest update
08/08/2023
Trademark type
Combined
Nice classes
35, 42
Filing date
06/27/2022
Registration date
08/08/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/08/2023
Last transaction
08/08/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
01/08/2020
First use in commerce
01/08/2020
Drawing code
3
Owner type
03
Owner location
Woburn, MA, US
Examiner
GEBHARDT, JACQUELINE D
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of three shaded quadrilaterals creating two diagonal lines, with two smaller quadrilaterals touching corners to the left of a longer quadrilateral, to the left of the literal element "ANAGENEX".
Holders and representatives
Holders
Anagenex, Inc.
Representatives
NIQ HOWARD
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Providing advertisingmarketing and promotional services for the pharmaceutical and medical industry; Providing advertisingmarketing and promotional services for the pharmaceutical and medical products of others; Providing business intelligence services in the fields of medical devicespharmaceuticals and the life sciences
Class 42
Providing a website featuring non-downloadable software using artificial intelligence for finding and marketing FDA approved pharmaceuticals to patients; Providing medical and scientific research information in the fields of pharmaceuticals and genetics
Publications
History of USPTO decisions and trademark events.
14 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/08/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/23/2023
PUBO
PUBLISHED FOR OPPOSITION
05/23/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/03/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/18/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
04/11/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/11/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
04/11/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/11/2023
DOCK
ASSIGNED TO EXAMINER
03/30/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/16/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/15/2022
NWAP
NEW APPLICATION ENTERED
06/30/2022
Continuous trademark protection
Get notified about every new filing that threatens ANAGENEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.